chr17-60600574-T-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_003620.4(PPM1D):​c.160T>G​(p.Ser54Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

PPM1D
NM_003620.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.265
Variant links:
Genes affected
PPM1D (HGNC:9277): (protein phosphatase, Mg2+/Mn2+ dependent 1D) The protein encoded by this gene is a member of the PP2C family of Ser/Thr protein phosphatases. PP2C family members are known to be negative regulators of cell stress response pathways. The expression of this gene is induced in a p53-dependent manner in response to various environmental stresses. While being induced by tumor suppressor protein TP53/p53, this phosphatase negatively regulates the activity of p38 MAP kinase, MAPK/p38, through which it reduces the phosphorylation of p53, and in turn suppresses p53-mediated transcription and apoptosis. This phosphatase thus mediates a feedback regulation of p38-p53 signaling that contributes to growth inhibition and the suppression of stress induced apoptosis. This gene is located in a chromosomal region known to be amplified in breast cancer. The amplification of this gene has been detected in both breast cancer cell line and primary breast tumors, which suggests a role of this gene in cancer development. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.08771077).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PPM1DNM_003620.4 linkuse as main transcriptc.160T>G p.Ser54Ala missense_variant 1/6 ENST00000305921.8
PPM1DXR_007065507.1 linkuse as main transcriptn.382T>G non_coding_transcript_exon_variant 1/7
PPM1DXR_934577.3 linkuse as main transcriptn.382T>G non_coding_transcript_exon_variant 1/7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PPM1DENST00000305921.8 linkuse as main transcriptc.160T>G p.Ser54Ala missense_variant 1/61 NM_003620.4 P1O15297-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 18, 2021The c.160T>G (p.S54A) alteration is located in exon 1 (coding exon 1) of the PPM1D gene. This alteration results from a T to G substitution at nucleotide position 160, causing the serine (S) at amino acid position 54 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
4.5
DANN
Benign
0.90
DEOGEN2
Benign
0.30
.;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.090
N
LIST_S2
Benign
0.19
T;T
M_CAP
Benign
0.053
D
MetaRNN
Benign
0.088
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N;N
MutationTaster
Benign
1.0
N
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-0.68
.;N
REVEL
Benign
0.052
Sift
Benign
0.32
.;T
Sift4G
Benign
0.76
T;T
Polyphen
0.0
.;B
Vest4
0.14
MutPred
0.26
Loss of phosphorylation at S54 (P = 0.0017);Loss of phosphorylation at S54 (P = 0.0017);
MVP
0.32
MPC
0.99
ClinPred
0.11
T
GERP RS
2.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.8
Varity_R
0.071
gMVP
0.085

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr17-58677935; API